198 related articles for article (PubMed ID: 8930187)
1. Pharmacokinetic/pharmacodynamic relationship of benzodiazepines in the direct cortical stimulation model of anticonvulsant effect.
Hoogerkamp A; Arends RH; Bomers AM; Mandema JW; Voskuyl RA; Danhof M
J Pharmacol Exp Ther; 1996 Nov; 279(2):803-12. PubMed ID: 8930187
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity.
Mandema JW; Sansom LN; Dios-Vièitez MC; Hollander-Jansen M; Danhof M
J Pharmacol Exp Ther; 1991 Apr; 257(1):472-8. PubMed ID: 1850477
[TBL] [Abstract][Full Text] [Related]
3. In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil.
Mandema JW; Tukker E; Danhof M
J Pharmacol Exp Ther; 1992 Jan; 260(1):36-44. PubMed ID: 1309878
[TBL] [Abstract][Full Text] [Related]
4. The effects of benzodiazepines on urotensin II-stimulated norepinephrine release from rat cerebrocortical slices.
Kawaguchi Y; Ono T; Kudo M; Kushikata T; Hashiba E; Yoshida H; Kudo T; Furukawa K; Douglas SA; Hirota K
Anesth Analg; 2009 Apr; 108(4):1177-81. PubMed ID: 19299782
[TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus effects of positive GABAA modulators and other anxiolytics, sedatives, and anticonvulsants in untreated and diazepam-treated monkeys.
McMahon LR; France CP
J Pharmacol Exp Ther; 2003 Jan; 304(1):109-20. PubMed ID: 12490581
[TBL] [Abstract][Full Text] [Related]
6. Azirino[1, 2-d][1, 4]benzodiazepine derivatives and related 1,4-benzodiazepines as anticonvulsant agents in DBA/2 mice.
De Sarro G; Chimirri A; Zappala M; Guisti P; Lipartiti M; De Sarro A
Gen Pharmacol; 1996 Oct; 27(7):1155-62. PubMed ID: 8981061
[TBL] [Abstract][Full Text] [Related]
7. CNS 7056: a novel ultra-short-acting Benzodiazepine.
Kilpatrick GJ; McIntyre MS; Cox RF; Stafford JA; Pacofsky GJ; Lovell GG; Wiard RP; Feldman PL; Collins H; Waszczak BL; Tilbrook GS
Anesthesiology; 2007 Jul; 107(1):60-6. PubMed ID: 17585216
[TBL] [Abstract][Full Text] [Related]
8. Modelling of the pharmacodynamics and pharmacodynamic interactions of CNS active drugs.
Danhof M; Mandema JW
Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):516-9. PubMed ID: 1490817
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological analysis of the effects of benzodiazepines on punished schedule-induced polydipsia in rats.
Pellón R; Ruíz A; Lamas E; Rodríguez C
Behav Pharmacol; 2007 Feb; 18(1):81-7. PubMed ID: 17218801
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic-pharmacodynamic modeling of the anticonvulsant and electroencephalogram effects of phenytoin in rats.
Della Paschoa OE; Mandema JW; Voskuyl RA; Danhof M
J Pharmacol Exp Ther; 1998 Feb; 284(2):460-6. PubMed ID: 9454785
[TBL] [Abstract][Full Text] [Related]
11. Adaptive changes in the pharmacodynamics of midazolam in different experimental models of epilepsy: kindling, cortical stimulation and genetic absence epilepsy.
Cleton A; Voskuyl RA; Danhof M
Br J Pharmacol; 1998 Oct; 125(4):615-20. PubMed ID: 9831893
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the pharmacodynamics of several antiepileptic drugs in a direct cortical stimulation model of anticonvulsant effect in the rat.
Hoogerkamp A; Vis PW; Danhof M; Voskuyl RA
J Pharmacol Exp Ther; 1994 May; 269(2):521-8. PubMed ID: 8182521
[TBL] [Abstract][Full Text] [Related]
13. The effects of benzodiazepines on orexinergic systems in rat cerebrocortical slices.
He Y; Kudo M; Kudo T; Kushikata T; Li E; Hirota K
Anesth Analg; 2007 Feb; 104(2):338-40. PubMed ID: 17242090
[TBL] [Abstract][Full Text] [Related]
14. Bidirectional effects of benzodiazepine binding site ligands in the passive avoidance task: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
Behav Brain Res; 2005 Mar; 158(2):293-300. PubMed ID: 15698896
[TBL] [Abstract][Full Text] [Related]
15. Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures.
Löscher W; Potschka H; Rieck S; Tipold A; Rundfeldt C
Epilepsia; 2004 Oct; 45(10):1228-39. PubMed ID: 15461677
[TBL] [Abstract][Full Text] [Related]
16. Biphasic actions of the benzodiazepine receptor inverse agonist RU34347 in the rat cerebellar slice.
Pringle AK; Gardner CR; Walker RJ
Brain Res; 1996 Apr; 715(1-2):155-62. PubMed ID: 8739634
[TBL] [Abstract][Full Text] [Related]
17. Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands.
Fradley RL; Guscott MR; Bull S; Hallett DJ; Goodacre SC; Wafford KA; Garrett EM; Newman RJ; O'Meara GF; Whiting PJ; Rosahl TW; Dawson GR; Reynolds DS; Atack JR
J Psychopharmacol; 2007 Jun; 21(4):384-91. PubMed ID: 17092983
[TBL] [Abstract][Full Text] [Related]
18. Effects of drugs acting on the GABA-benzodiazepine receptor complex on flurothyl-induced seizures in Mongolian gerbils.
Hashimoto Y; Araki H; Suemaru K; Gomita Y
Eur J Pharmacol; 2006 May; 536(3):241-7. PubMed ID: 16581068
[TBL] [Abstract][Full Text] [Related]
19. Apparent pA2 values of benzodiazepine antagonists and partial agonists in monkeys.
Paronis CA; Bergman J
J Pharmacol Exp Ther; 1999 Sep; 290(3):1222-9. PubMed ID: 10454498
[TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant drugs differentially suppress individual ictal signs: a pharmacokinetic/pharmacodynamic analysis in the cortical stimulation model in the rat.
Jonker DM; van de Mheen C; Eilers PH; Kruk MR; Voskuyl RA; Danhof M
Behav Neurosci; 2003 Oct; 117(5):1076-85. PubMed ID: 14570556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
